MetLife (MET) is currently experiencing robust momentum in the life insurance and benefits sector, which the broader market has not yet fully recognized. In the first quarter, the company's core premiums and fees increased by 10%, driven by strong demand both internationally and domestically, with Asia seeing a 22% rise, Latin America 20%, and US Group Benefits 15%.
The company is leveraging artificial intelligence to enhance efficiency, aiming for annual margin expansion of 20–25 basis points by keeping expense growth below revenue increases.
Analysts project nearly 25% growth in earnings per share (EPS) over the next two years, from an expected $9.94 in fiscal year 2026 to $12.40 in fiscal year 2028, with about 5% of this growth attributed to share buybacks, supported by a remaining $1.2 billion in the buyback program. MetLife's return on equity (ROE) stands at an average of 17.2%, within its target range of 15–17%.
Given these strong fundamentals, a suggested trading strategy involves a September 77.5/87.5/92.5 call spread risk reversal, which allows investors to benefit from MetLife's upward momentum while minimizing downside risk. This strategy also takes advantage of the upcoming earnings report on August 6th, as options premiums typically decrease after such events.
Overall, MetLife's strong sales, favorable underwriting conditions, and rising equity markets position it well for continued growth, making it a compelling investment choice